SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : ajtj's Post-Lobotomy Market Charts and Thoughts -- Ignore unavailable to you. Want to Upgrade?

To: Qone0 who wrote (18049)2/15/2021 12:21:09 PM
From: Sun Tzu  Respond to of 97558
 
There is also empirical evidence that the immunity lasts much longer (some people believe up to 10 years, but that assumes the mutations remain benign).

If CV19 immunity was short lived, then given the millions of people who got it, by now we would have a long list of people who got it twice. But that list is pretty short. So for most people the immunity lasts at least a year.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News